Riskpilot← Back to searchSign inGet full accessEpisurf Operations AB
ABActiveOrg 5569217739Karlavägen 60 5trManufacture of medical and dental instruments and supplies · NACE 3250Est. 20130 employees
Revenue 2024
SEK 9,2M
+19% vs 2023
EBITDA margin
-71.9%
-37% vs 2023
Equity ratio
8.9%
Financial strength
Net profit 2024
SEK -6,7M
-40% vs 2023
| Revenue | SEK 9,2M | +19% |
| EBITDA | SEK -6,6M | -37% |
| Net profit | SEK -6,7M | -40% |
| Total assets | SEK 5,3M | -57% |
| Equity | SEK 473K | +1113% |
| Employees | 0 | — |
Legal name
Episurf Operations AB
Org number
5569217739
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
6 februari 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av Flodström, Eva Katarina
Company purpose
Bolaget skall direkt eller genom hel- eller delägda bolag utveckla, marknadsföra och sälja medicinteknisk utrustning, direkt eller indirekt äga och förvalta fast eller lös egendom samt därmed förenlig verksamhet.
Address
Karlavägen 60 5tr
Email
info@episurf.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 2 869 | 3 869 | 4 338 | 5 437 | 5 427 | 7 694 | 9 186 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −795 | −731 | −1 939 | −2 253 | −3 129 | −4 631 | −6 637 | −3 056 | −4 837 | −6 605 |
| Depreciation & amort. | −8 | −23 | −30 | −30 | −25 | −22 | −7 | −0 | −0 | −0 |
| EBIT | −803 | −754 | −1 969 | −2 283 | −3 154 | −4 653 | −6 644 | −3 056 | −4 837 | −6 605 |
| Net financials | −91 | −175 | — | — | — | — | — | −37 | 14 | −142 |
| Profit before tax | −543 | −928 | −1 969 | −2 283 | −3 154 | −4 654 | −6 644 | −3 094 | −4 824 | −6 746 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −543 | −928 | −1 969 | −2 283 | −3 154 | −4 654 | −6 644 | −3 094 | −4 824 | −6 746 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 100 | 4 640 | 6 352 | 5 971 | 4 628 | 12 185 | 11 752 | 8 261 | 12 338 | 5 334 |
| Equity | 50 | 96 | 365 | 309 | 714 | 398 | 848 | 345 | 39 | 473 |
| Long-term debt | 2 988 | 6 | 18 | 29 | 27 | 10 775 | 9 938 | 7 145 | 10 333 | 3 790 |
| Short-term debt | 62 | 4 538 | 5 969 | 5 632 | 3 887 | 1 013 | 966 | 771 | 1 966 | 1 072 |
| Total debt | 3 050 | 4 544 | 5 987 | 5 661 | 3 914 | 11 788 | 10 904 | 7 916 | 12 299 | 4 862 |
EBITDA margin
-71.9%
This company
15.8%
Market median
-555% vs market
20152024
Equity ratio
8.9%
This company
38.2%
Market median
-77% vs market
20152024
Return on equity
-1426.2%
This company
18.4%
Market median
-7851% vs market
20152024
Net profit margin
-73.4%
This company
8.1%
Market median
-1006% vs market
20152024
Asset turnover
1.72×
This company
1.12×
Market median
+54% vs market
20152024
Debt / equity
10.28×
This company
0.62×
Market median
-1558% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DT Chief Auditor | Chief Auditor | 2022 | — | — |
FI Chief Auditor | Chief Auditor | 2024 | — | — |
DJ Chief Auditor | Chief Auditor | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Episurf Medical AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Episurf Medical AB
Episurf Operations AB Board members of Episurf Operations AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Tobias Holmer Stråle | Chief Auditor | 0 companies |
| Fanny Ingrid Maria Govén | Chief Auditor | 0 companies |
| Duane John Swanson | Chief Auditor | 0 companies |
| Eva Katarina Flodström | Board of Directors | 0 companies |
| Pål Harald Gustaf Ryfors | Chairman | 0 companies |
| Leif Erik Sigfrid Ryd | Board of Directors | 0 companies |
| Veronica Wallin | Board of Directors | 0 companies |